32nd Annual Meeting 2019

VIDEO LINKS

CLICK ON ANY HIGHLIGHTED SESSION TO SEE VIDEOS

 

Friday, August 16, 2019

PLENARY SESSION 1

Multiple Myeloma
Chairs:  M. Qasim Ansari, M.D. | Antony Bakke, Ph.D., D(ABMLI)
Eszter Lazar-Molnar, Ph.D., D(ABMLI), D(ABHI)

Guidelines and Challenges in the Laboratory Detection of
Monoclonal Proteins
David F. Keren, M.D., The University of Michigan

Biology and Treatment of Myeloma
 Shaji Kumar, M.D., Mayo Clinic Rochester

The Use of Flow Cytometry in the Diagnosis of Multiple Myeloma
and Monitoring Treatment with MRD Detection:  Issues and Caveats
Mikhail Roshal, M.D., Ph.D., Memorial Sloan Kettering Cancer Center

Using Mass Spectrometry to Profile Antibody Repertoires
David L. Murray, M.D., Ph.D., Mayo Clinic

 

PLENARY SESSION 2

Hot Topics in Immunology: Big Data and How to Use It
Chairs:  Roshini Abraham, Ph.D., D(ABMLI) | Mohamed Elrefaei, M.D., Ph.D.

Clinical Decision Support for Primary Immunodeficiencies: Making Health
Information Systems Work for Patients and Providers
Nicholas L. Rider, D.O., FAAAAI, Texas Children’s Hospital, Baylor College of Medicine

The Application and Utility of a Primary Immunodeficiency Diagnosis Tool
Robert P. Nelson, Jr., M.D., Indiana University School of Medicine |
Eonimmune, LLC

Clinical Curation of Genomic Data Requires Big Data Analysis: ClinGen and
Other Approaches to Genomic Data Curation and Analysis
Michael S. Watson, M.S., Ph.D., FACMG, American College of Medical Genetics

 

 Saturday, August 17, 2019

PLENARY SESSION 3

Antinuclear Antibodies:  A Workshop on Current
Practices and Future Directions
Chairs:  Lisa Peterson, Ph.D., D(ABMLI) | Anne Tebo, Ph.D., D(ABMLI)

Past, Present and Future of Antinuclear Antibody Testing
Marvin Fritzler, M.D., Ph.D., Cumming School of Medicine, University of Calgary

Antinuclear Antibodies:  Analysis of Results from a Recent AMLI ANA Survey
Lisa K. Peterson, Ph.D., D(ABMLI), University of Utah
School of Medicine | ARUP Laboratories

ANA IFA: Technical Issues Affecting Reading and Interpreting ANA IFA Patterns
Susan S. Copple, M.S., MT(ASCP)SI, Inova Diagnostics

ANA Patterns and Titers:  Clinical Associations and Diagnostic Relevance
Mark Wener, M.D., University of Washington

Panel and Audience Discussion: The Grand Debate

 


ERWIN NETER MEMORIAL LECTURE
Autoantibodies: Good, Bad and Junk
Marvin J. Fritzler, M.D., Ph.D, University of Calgary

Sunday, August 18, 2019

PLENARY SESSION 4

Case Studies
Chairs:  Trivikram Dasu, Ph.D., D(ABMLI) | Sara Nandiwada, Ph.D., D(ABMLI)
Evangelos Ntrivalas, M.D., Ph.D., D(ABMLI), HCLD(ABB)

Systemic Lupus Erythematosus in a Child with Ulcerative Colitis
Lusia Sepiashvili, Ph.D., The Hospital for Sick Children

A Slow Burn: A Case of Smoldering Myeloma
David L. Murray, M.D., Ph.D., Mayo Clinic

Interpretation of an Elusive Pattern of Serum Protein Electrophoresis in
a
Patient with Refractory Multiple Myeloma
Eszter Lazar-Molnar, Ph.D., D(ABMLI), D(ABHI), University of Utah School of Medicine | ARUP Laboratories

Pneumococcal Vaccine Response in Adults with Cystic Fibrosis
Kimberly A. McBennett, M.D., Ph.D. | Tracey L. Bonfield, Ph.D., D(ABMLI), University
Hospitals, Rainbow Babies and Children’s Hospital, Case Western Reserve University

Monday, August 19, 2019

PLENARY SESSION 5

Vaccines
Chairs:  Thomas S. Alexander, Ph.D., D(ABMLI)
Amir A. Sadighi Akha, M.D., D.Phil., D(ABMLI) | Eric T. Weimer, Ph.D., D(ABMLI)

Vaccine Refusal: Who, Where, Why – and What to do About It
Mark C. Navin, Ph.D., Oakland University

The Effect of Age and Biological Sex on Immune Responses to Vaccination
Inna G. Ovsyannikova, Ph.D., Mayo Clinic College of Medicine, Mayo Clinic
Vaccine Research Group

Epitope Guided Design of Flavirus Recombinant Protein Subunit Vaccines
Stefan W. Metz, Ph.D., MSc., University of North Carolina at Chapel Hill

Clinical Vaccine Studies – A Laboratory Immunology Perspective
Marcela Pasetti, Ph.D., University of Maryland Center for Vaccine Development
and Global Health

Back